Literature DB >> 17996713

A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer.

Steve Braunstein1, Ksenia Karpisheva, Carolina Pola, Judith Goldberg, Tsivia Hochman, Herman Yee, Joan Cangiarella, Rezina Arju, Silvia C Formenti, Robert J Schneider.   

Abstract

Translational regulation is critical in cancer development and progression. Translation sustains tumor growth and development of a tumor vasculature, a process known as angiogenesis, which is activated by hypoxia. Here we first demonstrate that a majority of large advanced breast cancers overexpress translation regulatory protein 4E-BP1 and initiation factor eIF4G. Using model animal and cell studies, we then show that overexpressed 4E-BP1 and eIF4G orchestrate a hypoxia-activated switch from cap-dependent to cap-independent mRNA translation that promotes increased tumor angiogenesis and growth at the level of selective mRNA translation. Elevated levels of 4E-BP1 trigger hypoxia inhibition of cap-dependent mRNA translation at high-oxygen levels and, with eIF4G, increase selective translation of mRNAs containing internal ribosome entry sites (IRESs) that include key proangiogenic, hypoxia, and survival mRNAs. The switch from cap-dependent to cap-independent mRNA translation facilitates tumor angiogenesis and hypoxia responses in animal models.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996713     DOI: 10.1016/j.molcel.2007.10.019

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  138 in total

1.  The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis.

Authors:  T L Ng; G Leprivier; M D Robertson; C Chow; M J Martin; K R Laderoute; E Davicioni; T J Triche; P H B Sorensen
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

2.  Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells.

Authors:  Michael W Bronson; Sara Hillenmeyer; Richard W Park; Alexander S Brodsky
Journal:  Mol Endocrinol       Date:  2010-04-14

3.  Translational control of the abundance of cytoplasmic poly(A) binding protein in human cytomegalovirus-infected cells.

Authors:  Cesar Perez; Caleb McKinney; Uyanga Chulunbaatar; Ian Mohr
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

Review 4.  Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer.

Authors:  Biplab Dasgupta; Rishi Raj Chhipa
Journal:  Trends Pharmacol Sci       Date:  2015-12-20       Impact factor: 14.819

Review 5.  Nonsense-mediated RNA decay regulation by cellular stress: implications for tumorigenesis.

Authors:  Lawrence B Gardner
Journal:  Mol Cancer Res       Date:  2010-02-23       Impact factor: 5.852

Review 6.  Regulation of translation initiation in eukaryotes: mechanisms and biological targets.

Authors:  Nahum Sonenberg; Alan G Hinnebusch
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 7.  Heterogeneity and specialized functions of translation machinery: from genes to organisms.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Nat Rev Genet       Date:  2018-07       Impact factor: 53.242

8.  The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.

Authors:  Columba de la Parra; Elisa Otero-Franqui; Michelle Martinez-Montemayor; Suranganie Dharmawardhane
Journal:  J Biol Chem       Date:  2012-10-24       Impact factor: 5.157

9.  Parallel measurement of dynamic changes in translation rates in single cells.

Authors:  Kyuho Han; Ariel Jaimovich; Gautam Dey; Davide Ruggero; Oded Meyuhas; Nahum Sonenberg; Tobias Meyer
Journal:  Nat Methods       Date:  2013-11-10       Impact factor: 28.547

10.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.